Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Iveco Group published today the Informative Document concerning the sale of its Defence business to Leonardo S.p.A.
-
Landmark regulatory milestone makes the River stent available for adults with severe IIH – a debilitating, historically undertreated condition – who have failed medical therapy Serenity Medical...
-
Vancouver, British Columbia, March 31, 2026 (GLOBE NEWSWIRE) -- Surge Copper Corp. (TSXV: SURG) (OTCQB: SRGXF) (Frankfurt: G6D2) (“Surge” or the “Company”) is pleased to provide a corporate update...
-
TORONTO, March 31, 2026 (GLOBE NEWSWIRE) -- African Rainbow Minerals Limited (JSE: ARI) (A2X: ARI) (“ARM”) announces that it has signed a subscription agreement (the “Subscription Agreement”)...
-
LOS ANGELES, CA, March 31, 2026 (GLOBE NEWSWIRE) -- Today, DISQO, the leading provider of advertising intelligence, and Comcast Advertising, the advertising division of Comcast, the global media and...
-
Service cars, SUVs, work trucks and vans up to 12,000 lbs. in low-ceiling bays with new ALI-Certified BendPak 12APF open-top two-post lift.
-
Citeline, a leader in clinical solutions for the life sciences, announced an expanded strategic partnership with Recursion, a leading tech-bio company.
-
PONTE VEDRA, Fla., March 31, 2026 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company advancing novel therapies for life-threatening immune and...
-
IRVINE, Calif., March 31, 2026 (GLOBE NEWSWIRE) -- Ambros Therapeutics, Inc. today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a new...
-
IMNN-001 is the first frontline immunotherapy to demonstrate the potential for a clinically meaningful overall survival benefit in women newly diagnosed with advanced ovarian cancer Final Phase 2...